Thema
Journal Article
19
EC 2.7.10.1
9
Receptor, ErbB-2
9
Research Support, Non-U.S. Gov't
9
Chemotherapy
5
ERBB2 protein, human
5
Early breast cancer
5
Receptors, Estrogen
5
Review
5
Adjuvant therapy
4
Adjuvant treatment intensity customization
4
Escalation and de-escalation
4
Luminal subtype
4
Special histology
4
Triple-negative breast cancer
4
Tumor-infiltrating lymphocytes
4
WHO classification
4
breast cancer
4
Antineoplastic Agents
3
Biomarkers, Tumor
3
Krebs
3
Multicenter Study
3
Neoplasms
3
P188ANX8CK
3
Practice Guideline
3
Quinazolines
3
Receptors, Progesterone
3
Trastuzumab
3
methods
3
0VUA21238F
2
HER2
2
Lapatinib
2
Meta-Analysis
2
Molecular Targeted Therapy
2
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
2
Pyridines
2
Randomized Controlled Trial
2
Systematic Review
2
Targeted drug delivery
2
drug therapy
2
prognosis
2
therapeutic use
2
trastuzumab
2
tumor-infiltrating lymphocytes
2
143011-72-7
1
234248D0HH
1
6-month
1
Adjuvant chemotherapy
1
Anthracyclines
1
Antibodies, Monoclonal, Humanized
1
mehr ...